4.3 Article

NANETS Treatment Guidelines Well-Differentiated Neuroendocrine Tumors of the Stomach and Pancreas

Journal

PANCREAS
Volume 39, Issue 6, Pages 735-752

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/MPA.0b013e3181ebb168

Keywords

islet cell; gastric; carcinoid; guidelines; review

Funding

  1. Intramural NIH HHS [Z01 DK053200-17, Z01 DK053215-02, ZIA DK053200-19, Z99 DK999999] Funding Source: Medline
  2. NCI NIH HHS [K23 CA093401-01A2, K23 CA093401-03, K23 CA093401-05, K23 CA093401-02, K23 CA093401, K23 CA093401-04] Funding Source: Medline

Ask authors/readers for more resources

Well-differentiated neuroendocrine tumors (NETs) of the stomach and pancreas represent 2 major subtypes of gastrointestinal NETs. Historically, there has been little consensus on the classification and management of patients with these tumor subtypes. We provide an overview of well-differentiated NETs of the stomach and pancreas and describe consensus guidelines for the treatment of patients with these malignancies.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available